BSSFA
BIO icon

Baron Silver Stevens Financial Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Baron Silver Stevens Financial Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5
Closed -$2K – 95
2020
Q4 		$2K Buy
+5
New +$2.85K ﹤0.01% 385

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Baron Silver Stevens Financial Advisors's BIO Position: Q1 2021 in Review

Baron Silver Stevens Financial Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2021, closing a stake of 5 shares — an estimated $2K sold.

Baron Silver Stevens Financial Advisors first reported a position in BIO in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 491 funds tracked by Wall St. Rank hold BIO as of Q1 2021.

  • Baron Silver Stevens Financial Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q1 2021 after selling out during the quarter.
  • Baron Silver Stevens Financial Advisors sold 5 Bio-Rad Laboratories Class A shares in Q1 2021, an estimated $2K.
  • Baron Silver Stevens Financial Advisors first reported a position in Bio-Rad Laboratories Class A in Q4 2020 and held it in 1 quarter.
  • Baron Silver Stevens Financial Advisors's Bio-Rad Laboratories Class A position peaked at $2K in Q4 2020.
  • 491 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2021.

Based on Baron Silver Stevens Financial Advisors's 13F filing for Q1 2021, filed 27 Apr 2021.